Reversal of Multidrug Resistance by Symmetrical Selenoesters in Colon Adenocarcinoma Cells

Reversal of Multidrug Resistance by Symmetrical Selenoesters in Colon Adenocarcinoma Cells

Recently, selenium containing derivatives have attracted more attention in medicinal chemistry. In the present work, the anticancer activity of symmetrical selenoesters was investigated by studying the reversal of efflux pump-related and apoptosis resistance in sensitive and resistant human colon ad...

Full description

Bibliographic Details
Main Authors:	Bálint Rácz, Annamária Kincses, Krisztián Laczi, Gábor Rákhely, Enrique Domínguez-Álvarez, Gabriella Spengler
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Pharmaceutics
Subjects:	multidrug resistance P-glycoprotein or ABCB1 apoptosis selenoesters metastasis
Online Access:	https://www.mdpi.com/1999-4923/15/2/610

Similar Items

Biofilm Eradication by Symmetrical Selenoesters for Food-Borne Pathogens
by: Márta Nové, et al.
Published: (2020-04-01)

Cyano- and Ketone-Containing Selenoesters as Multi-Target Compounds against Resistant Cancers
by: Nikoletta Szemerédi, et al.
Published: (2021-09-01)

Ketone- and Cyano-Selenoesters to Overcome Efflux Pump, Quorum-Sensing, and Biofilm-Mediated Resistance
by: Nikoletta Szemerédi, et al.
Published: (2020-12-01)

Peptidyl ω-Asp Selenoesters Enable Efficient Synthesis of N-Linked Glycopeptides
by: Jing-Jing Du, et al.
Published: (2020-05-01)

Novel Selenoesters as a Potential Tool in Triple-Negative Breast Cancer Treatment
by: Dominika Radomska, et al.
Published: (2022-09-01)

Identification and Empiric Evaluation of New Inhibitors of the Multidrug Transporter P-Glycoprotein (ABCB1)
by: Yasmeen Cheema, et al.
Published: (2023-03-01)

Selective Fluorescent Probes for High-Throughput Functional Diagnostics of the Human Multidrug Transporter P-Glycoprotein (ABCB1)
by: Edit Szabó, et al.
Published: (2022-09-01)

C3435T Polymorphism of the ABCB1 gene in the Yakut Population
by: Nadezhda I. Pavlova, et al.
Published: (2021-09-01)

Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents
by: Chung-Pu Wu, et al.
Published: (2021-07-01)

TMPE Derived from Saffron Natural Monoterpene as Cytotoxic and Multidrug Resistance Reversing Agent in Colon Cancer Cells
by: Kamila Środa-Pomianek, et al.
Published: (2020-10-01)

Antimicrobial, Anticancer and Multidrug-Resistant Reversing Activity of Novel Oxygen-, Sulfur- and Selenoflavones and Bioisosteric Analogues
by: Małgorzata Anna Marć, et al.
Published: (2020-12-01)

Lycorine Carbamate Derivatives for Reversing P-glycoprotein-Mediated Multidrug Resistance in Human Colon Adenocarcinoma Cells
by: Shirley A. R. Sancha, et al.
Published: (2023-01-01)

Pharmaceutical and Safety Profile Evaluation of Novel Selenocompounds with Noteworthy Anticancer Activity
by: Małgorzata Anna Marć, et al.
Published: (2022-02-01)

Isobavachalcone as an Active Membrane Perturbing Agent and Inhibitor of ABCB1 Multidrug Transporter
by: Anna Palko-Łabuz, et al.
Published: (2021-07-01)

5-Arylidenerhodanines as P-gp Modulators: An Interesting Effect of the Carboxyl Group on ABCB1 Function in Multidrug-Resistant Cancer Cells
by: Ewa Żesławska, et al.
Published: (2022-09-01)

ABCB1 Does Not Require the Side-Chain Hydrogen-Bond Donors Gln<sup>347</sup>, Gln<sup>725</sup>, Gln<sup>990</sup> to Confer Cellular Resistance to the Anticancer Drug Taxol
by: Keerthana Sasitharan, et al.
Published: (2021-08-01)

First report of nt230(del4) mutation in the MDR1 gene in German Shepherds in Southern Brazil
by: Ananda da Rocha Pires, et al.
Published: (2021-06-01)

Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells
by: Weiguo Feng, et al.
Published: (2020-06-01)

New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria
by: Gabriella Spengler, et al.
Published: (2017-03-01)

Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells
by: Lei Zhang, et al.
Published: (2022-04-01)

Antiproliferative and cytotoxic activities of furocoumarins of Ducrosia anethifolia
by: Javad Mottaghipisheh, et al.
Published: (2018-01-01)

Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance
by: Aneta Kaczor, et al.
Published: (2020-05-01)

Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells
by: Yongchao Zhang, et al.
Published: (2020-11-01)

Cell Death Effects Induced by Sulforaphane and Allyl Isothiocyanate on P-Glycoprotein Positive and Negative Variants in L1210 Cells
by: Szilvia Kontar, et al.
Published: (2020-04-01)

Apoptosis Sensitization by Euphorbia Factor L1 in ABCB1-Mediated Multidrug Resistant K562/ADR Cells
by: Zhong-Zhen Zhao, et al.
Published: (2013-10-01)

Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in vitro and in vivo
by: Xu Wu, et al.
Published: (2021-07-01)

The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells
by: Rowa Bakadlag, et al.
Published: (2023-01-01)

Complex interplay between the P-glycoprotein multidrug efflux pump and the membrane: its role in modulating protein function
by: Frances Jane Sharom
Published: (2014-03-01)

Genotype and haplotype analysis of ABCB1 at 1236, 2677 and 3435 among systemic sclerosis patients
by: Małgorzata Barańska, et al.
Published: (2017-07-01)

Multidrug Resistance in Cancer Cells: Focus on a Possible Strategy Plan to Address Colon Carcinoma Cells
by: Chenmala Karthika, et al.
Published: (2022-05-01)

Glicoproteína-P, resistência a múltiplas drogas (MDR) e relação estrutura-atividade de moduladores P-glycoprotein and multidrug resistance: structure-activity relationships of modulators
by: Paula C. Huber, et al.
Published: (2010-01-01)

Benzoxazole-Based Metal Complexes to Reverse Multidrug Resistance in Bacteria
by: Annamária Kincses, et al.
Published: (2020-09-01)

Non-Nutritive Sweeteners Acesulfame Potassium and Sucralose Are Competitive Inhibitors of the Human P-glycoprotein/Multidrug Resistance Protein 1 (PGP/MDR1)
by: Laura Danner, et al.
Published: (2023-02-01)

Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines
by: Dinah Linke, et al.
Published: (2022-12-01)

ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
by: Mugosa Snezana, et al.
Published: (2021-02-01)

P-glycoprotein expression in experimental thyroid dysfunction
by: Aleksey Vladimirovich Shchul'kin, et al.
Published: (2015-07-01)

Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells
by: Olga Wesołowska, et al.
Published: (2020-04-01)

Effects of Myristicin in Association with Chemotherapies on the Reversal of the Multidrug Resistance (MDR) Mechanism in Cancer
by: Elisa Frederico Seneme, et al.
Published: (2022-10-01)

Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells
by: Jelena Dinić, et al.
Published: (2023-12-01)

Genetics of <i>ABCB1</i> in Cancer
by: Katie T. Skinner, et al.
Published: (2023-08-01)